BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 17310240)

  • 21. Antioxidant N-acetylcysteine blocks nerve growth factor-induced H2O2/ERK signaling in PC12 cells.
    Yang LY; Ko WC; Lin CM; Lin JW; Wu JC; Lin CJ; Cheng HH; Shih CM
    Ann N Y Acad Sci; 2005 May; 1042():325-37. PubMed ID: 15965078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.
    Iacopino F; Lama G; Angelucci C; Sica G
    Int J Oncol; 2006 Jul; 29(1):237-47. PubMed ID: 16773205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling.
    Waetzig V; Herdegen T
    Mol Cell Neurosci; 2005 Sep; 30(1):67-78. PubMed ID: 16006144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PKC isoenzymes differentially modulate the effect of thrombin on MAPK-dependent RPE proliferation.
    Palma-Nicolas JP; López E; López-Colomé AM
    Biosci Rep; 2008 Dec; 28(6):307-17. PubMed ID: 18636965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling pathways for PC12 cell differentiation: making the right connections.
    Vaudry D; Stork PJ; Lazarovici P; Eiden LE
    Science; 2002 May; 296(5573):1648-9. PubMed ID: 12040181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Na+/K+/Cl- cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK.
    Panet R; Eliash M; Atlan H
    J Cell Physiol; 2006 Mar; 206(3):578-85. PubMed ID: 16222701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
    Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
    Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.
    Andreu-Pérez P; Esteve-Puig R; de Torre-Minguela C; López-Fauqued M; Bech-Serra JJ; Tenbaum S; García-Trevijano ER; Canals F; Merlino G; Avila MA; Recio JA
    Sci Signal; 2011 Sep; 4(190):ra58. PubMed ID: 21917714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selenazoles (selenium compounds) facilitate survival of cultured rat pheochromocytoma PC12 cells after serum-deprivation and stimulate their neuronal differentiation via activation of Akt and mitogen-activated protein kinase, respectively.
    Nishina A; Sekiguchi A; Fukumoto RH; Koketsu M; Furukawa S
    Biochem Biophys Res Commun; 2007 Jan; 352(2):360-5. PubMed ID: 17126295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling.
    Li H; Pinto AR; Duan W; Li J; Toh BH; Liu JP
    J Neurochem; 2005 Nov; 95(3):891-901. PubMed ID: 16248892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes.
    Clerk A; Aggeli IK; Stathopoulou K; Sugden PH
    Cell Signal; 2006 Feb; 18(2):225-35. PubMed ID: 15936927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E; Mudge AW; Maycox PR
    Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
    Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.
    Mayer SI; Rössler OG; Endo T; Charnay P; Thiel G
    J Cell Sci; 2009 Sep; 122(Pt 18):3340-50. PubMed ID: 19706684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade.
    Robubi A; Mueller T; Fueller J; Hekman M; Rapp UR; Dandekar T
    Biol Chem; 2005 Nov; 386(11):1165-71. PubMed ID: 16307482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of calcium-dependent kinases and epidermal growth factor receptor regulate muscarinic acetylcholine receptor-mediated MAPK/ERK activation in thyroid epithelial cells.
    Montiel M; Quesada J; Jiménez E
    Cell Signal; 2007 Oct; 19(10):2138-46. PubMed ID: 17643958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
    Kiel C; Serrano L
    Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.